Cargando…
Inhibited Wnt Signaling Causes Age-Dependent Abnormalities in the Bone Matrix Mineralization in the Apert Syndrome FGFR2(S252W/+) Mice
Apert syndrome (AS) is a type of autosomal dominant disease characterized by premature fusion of the cranial sutures, severe syndactyly, and other abnormalities in internal organs. Approximately 70% of AS cases are caused by a single mutation, S252W, in fibroblast growth factor receptor 2 (FGFR2). T...
Autores principales: | Zhang, Li, Chen, Peng, Chen, Lin, Weng, Tujun, Zhang, Shichang, Zhou, Xia, Zhang, Bo, Liu, Luchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333342/ https://www.ncbi.nlm.nih.gov/pubmed/25693202 http://dx.doi.org/10.1371/journal.pone.0112716 |
Ejemplares similares
-
A Ser252Trp Mutation in Fibroblast Growth Factor Receptor 2 (FGFR2) Mimicking Human Apert Syndrome Reveals an Essential Role for FGF Signaling in the Regulation of Endochondral Bone Formation
por: Chen, Peng, et al.
Publicado: (2014) -
A novel FGFR2 (S137W) mutation resulting in Apert syndrome: A case report
por: Shi, Qingyang, et al.
Publicado: (2020) -
Novel Molecular Pathways Elicited by Mutant FGFR2 May Account for Brain Abnormalities in Apert Syndrome
por: Yeh, Erika, et al.
Publicado: (2013) -
Therapeutic Effect of Nanogel-Based Delivery of Soluble FGFR2 with S252W Mutation on Craniosynostosis
por: Yokota, Masako, et al.
Publicado: (2014) -
Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R )mice
por: Wang, Yingli, et al.
Publicado: (2010)